Research reveals key role of mucin modification in muco-obstructive diseases

With each breath, a human may inhale thousands of harmful microbes into the lungs. Mucus, the gel-like moist substance coating the airways, is one of the first lines of defense and aids in removal these microbes.

Billionaire Mets Owner Steve Cohen Donates $5M For Psychedelics Research

In a landmark advancement for psychedelics science, the Multidisciplinary Association for Psychedelic Studies’ Public Benefit Corporation (MAPS PBC) has unveiled its intent to lodge a New Drug Application (NDA)

June 23, 2023

Tailoring polymeric micelles for improved olaparib solubility and drug release

Olaparib is a selective poly (ADP-ribose) polymerase inhibitor. However, its clinical application is hindered by low solubility and undesired pharmacokinetic profiles (e.g., relatively short circulation).

May 23, 2024

Women more likely to experience digital overload due to work-family demands

When it comes to juggling using digital technology for both work and family, women are at greater risk than men of ‘digital overload’, according to

August 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.